Arovella Therapeutics Ltd
ASX:ALA
Arovella Therapeutics Ltd
ASX:ALA
Price:
0.07
AUD
1.45%
Market Closed
Market Cap:
AU$84.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Arovella Therapeutics Ltd
ASX:ALA
|
AU |
|
S
|
Swadeshi Polytex Ltd
BSE:503816
|
IN |
|
Anpario PLC
LSE:ANP
|
UK |
|
CTEK AB (publ)
STO:CTEK
|
SE |
|
Select Medical Holdings Corp
NYSE:SEM
|
US |
|
State Trading Corporation of India Ltd
NSE:STCINDIA
|
IN |
|
T
|
TFE Co Ltd
KOSDAQ:425420
|
KR |
|
A
|
Attica Holdings SA
XBER:AAE1
|
GR |
|
D
|
Downstream SA
WSE:DOW
|
PL |
|
Media Chinese International Ltd
HKEX:685
|
HK |
Multiples-Based Value
The
Multiples-Based Value for
Arovella Therapeutics Ltd (ALA)
under the Base Case is
hidden
AUD.
Compared with the current market price of 0.07 AUD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALA Multiples-Based Value
LOCKED
Multiples Across Competitors
ALA Competitors Multiples
Arovella Therapeutics Ltd Competitors
Arovella Therapeutics Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Arovella Therapeutics Ltd
ASX:ALA
|
84.1m AUD | 150.1 | -10.6 | -4.5 | -4.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD | 13.5 | 42.6 | 28.8 | 30.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP | 5.2 | 30 | 16.6 | 23.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD | 4.5 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.1 | 20.7 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD | 2.4 | 16.5 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
